Advertisement
Research Article| Volume 42, ISSUE 3, P351-356, February 2006

Download started.

Ok

Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies

  • Author Footnotes
    1 Previous address: Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
    G.H. de Bock
    Correspondence
    Corresponding authors. Tel.: +31 50 3632852 (G.H. de Bock), +31 71 5262309 (C.J. van de Velde); fax: +31 50 36111738 (G.H. de Bock), +31 71 5266750 (C.J. van de Velde).
    Footnotes
    1 Previous address: Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
    Affiliations
    Department of Epidemiology, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Author Footnotes
    2 Previous European Organisation for Research and Treatment of Cancer (EORTC) Fellow.
    J.A. van der Hage
    Footnotes
    2 Previous European Organisation for Research and Treatment of Cancer (EORTC) Fellow.
    Affiliations
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Search for articles by this author
  • H. Putter
    Affiliations
    Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands
    Search for articles by this author
  • J. Bonnema
    Affiliations
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Search for articles by this author
  • H. Bartelink
    Affiliations
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Search for articles by this author
  • C.J. van de Velde
    Correspondence
    Corresponding authors. Tel.: +31 50 3632852 (G.H. de Bock), +31 71 5262309 (C.J. van de Velde); fax: +31 50 36111738 (G.H. de Bock), +31 71 5266750 (C.J. van de Velde).
    Affiliations
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Search for articles by this author
  • Author Footnotes
    1 Previous address: Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
    2 Previous European Organisation for Research and Treatment of Cancer (EORTC) Fellow.
DOI:https://doi.org/10.1016/j.ejca.2005.10.006
Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies
Previous ArticleProspective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma
Next ArticlePrognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma

      Abstract

      The aim of this study was to evaluate prognostic factors for isolated loco-regional recurrence in patients treated for invasive stage I or II breast cancer. The study population comprised 3602 women who had undergone primary surgery for early stage breast cancer, who were enrolled in European Organisation for Research and Treatment of Cancer (EORTC) trials 10801, 10854, or 10902, by breast conservation (55%) and mastectomy (45%). The median follow-up time varied from 5.3 (range: 0.6–9.5) to 11.9 years (range: 0.6–17.4). Main outcome was the occurrence of isolated loco-regional recurrence. The results of multivariate analysis showed that younger age and breast conservation were risk factors for isolated loco-regional recurrence (breast cancer under 35 years of age versus over 50 years of age: hazard ratio 2.80 (95% CI 1.41–5.60)); breast cancer age 35–50 years versus over 50 years: hazard ratio 1.72 (95% CI 1.17–2.54); breast conservation (hazard ratio: 1.82 (95% CI 1.17–2.86)). After perioperative chemotherapy, less isolated loco-regional recurrences were observed (hazard ratio 0.63 (95% CI 0.44–0.91)). No significant interaction effects were observed. It is concluded that young age and breast conserving therapy are both independent predictors for isolated loco-regional recurrence. As an isolated loco-regional recurrence is a potentially curable condition, women treated with breast conservation or diagnosed with breast cancer at a young age should be monitored closely to detect local recurrence at an early stage.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Vicini F.A.
        • Kestin L.
        • Huang R.
        • et al.
        Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?.
        Cancer. 2003; 97: 910-919
        View in Article
        • Harris E.E.
        • Hwang W.T.
        • Seyednejad F.
        • et al.
        Prognosis after regional lymph node recurrence in patients with stage I–II breast carcinoma treated with breast conservation therapy.
        Cancer. 2003; 98: 2144-2151
        View in Article
        • Veronesi U.
        • Marubini E.
        • Del Vecchio M.
        • et al.
        Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.
        J Natl Cancer Inst. 1995; 87: 19-27
        View in Article
        • Fisher B.
        • Anderson S.
        • Fisher E.R.
        • et al.
        Significance of ipsilateral breast tumour recurrence after lumpectomy.
        Lancet. 1991; 338: 327-331
        View in Article
        • Dongen J.Av.
        • Voogd A.C.
        • Fentiman I.S.
        • et al.
        Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organisation for Research and Treatment of Cancer 10801 trial.
        J Natl Cancer Inst. 2000; 92: 1143-1150
        View in Article
        • Fisher B.
        • Anderson S.
        • Bryant J.
        • et al.
        Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
        New Engl J Med. 2002; 347: 1233-1241
        View in Article
        • Veronesi U.
        • Cascinelli N.
        • Mariani L.
        • et al.
        Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.
        New Engl J Med. 2002; 347: 1227-1232
        View in Article
        • Arriagada R.
        • Le M.G.
        • Guinebretiere J.M.
        • et al.
        Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients.
        Ann Oncol. 2003; 14: 1617-1622
        View in Article
        • Elkhuizen P.H.
        • van de Vijver M.J.
        • Hermans J.
        • et al.
        Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.
        Int J Radiat Oncol Biol Phys. 1998; 40: 859-867
        View in Article
        • Touboul E.
        • Buffat L.
        • Belkacemi Y.
        • et al.
        Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
        Int J Radiat Oncol Biol Phys. 1999; 43: 25-38
        View in Article
        • Horst K.C.
        • Smitt M.C.
        • Goffinet D.R.
        • et al.
        Predictors of local recurrence after breast-conservation therapy.
        Clin Breast Cancer. 2005; 5: 425-438
        View in Article
        • Huston T.L.
        • Simmons R.M.
        Locally recurrent breast cancer after conservation therapy.
        Am J Surg. 2005; 189: 229-235
        View in Article
        • Voogd A.C.
        • Nielsen M.
        • Peterse J.L.
        • et al.
        Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
        J Clin Oncol. 2001; 19: 1688-1697
        View in Article
        • Arriagada R.
        • Le M.G.
        • Contesso G.
        • et al.
        Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer.
        Ann Oncol. 2002; 13: 1404-1413
        View in Article
        • van Dongen J.A.
        • Bartelink H.
        • Fentiman I.S.
        • et al.
        Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.
        J Natl Cancer Inst Monogr. 1992; : 15-18
        View in Article
        • van Dongen J.A.
        • Bartelink H.
        • Fentiman I.S.
        • et al.
        Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
        Eur J Cancer. 1992; 28A: 801-805
        View in Article
        • Clahsen P.C.
        • van de Velde C.J.
        • Julien J.P.
        • et al.
        Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
        J Clin Oncol. 1996; 14: 745-753
        View in Article
        • Elkhuizen P.H.
        • van Slooten H.J.
        • Clahsen P.C.
        • et al.
        High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
        J Clin Oncol. 2000; 18: 1075-1083
        View in Article
        • van der Hage J.A.
        • van de Velde C.J.
        • Julien J.P.
        • et al.
        Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organisation for Research and Treatment of Cancer (EORTC) Trial 10854.
        Eur J Cancer. 2001; 37: 2184-2193
        View in Article
        • van der Hage J.A.
        • van de Velde C.J.
        • Julien J.P.
        • et al.
        Preoperative chemotherapy in primary operable breast cancer: results from the European Organisation for Research and Treatment of Cancer trial 10902.
        J Clin Oncol. 2001; 19: 4224-4237
        View in Article
        • Klein J.P.
        • Moeschberger M.L.
        Survival analysis: techniques for censored and truncated data.
        Springer-Verlag, New York2003
        View in Article
        • Voogd A.C.
        • van Oost F.J.
        • Rutgers E.J.
        • et al.
        Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
        Eur J Cancer. 2005; 41: 2637-2644
        View in Article

      23. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group. New Engl J Med 1995;333:1444–55.

        View in Article
        • Kroman N.
        • Holtveg H.
        • Wohlfahrt J.
        • et al.
        Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma.
        Cancer. 2004; 100: 688-693
        View in Article

      25. National Cancer Institute and Breast International Group. Available from www.nci.nih.gov/search/ViewClinicalTrials.aspx?cdrid=343619&version=HealthProfessional&protocolsearchid=1537001.

        View in Article
        • Ernst M.F.
        • Voogd A.C.
        • Coebergh J.W.
        • et al.
        Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.
        Eur J Cancer. 2004; 40: 487-493
        View in Article
        • Bartelink H.
        • Horiot J.C.
        • Poortmans P.
        • et al.
        Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
        New Engl J Med. 2001; 345: 1378-1387
        View in Article

      Article info

      Publication history

      Accepted: October 13, 2005
      Received in revised form: October 7, 2005
      Received: May 9, 2005

      Identification

      DOI: https://doi.org/10.1016/j.ejca.2005.10.006

      Copyright

      © 2005 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX